Affiliation:
1. College of Medicine, University of Florida, Gainesville, FL
2. Brigham and Women's Hospital and Harvard Medical School, Boston, MA
3. College of Pharmacy, University of Florida, Gainesville, FL
Abstract
Background
It is difficult to accurately determine prognosis of patients with hypertension and chronic stable coronary artery disease (
CAD
). Our aim was to construct a risk score for predicting important adverse events in this population.
Methods and Results
Patients with hypertension and chronic stable
CAD
enrolled in the
IN
ternational
VE
rapamil‐
SR
/Trandolapril
ST
udy (
INVEST
) comprised the study cohort. Candidate predictor variables were obtained from patients with at least 1 postbaseline visit. Patients were divided into development (n=18 484) and validation cohorts (n=2054). Cox regression model identified predictors of the primary outcome: all‐cause mortality, myocardial infarction, or stroke at a mean follow‐up of 2.3 years. The hazard ratio of each variable was rounded to the nearest integer to construct score weights. A score 0 to 4 defined low‐risk, 5 to 6 intermediate‐risk and ≥7 high‐risk. The following variables were retained in the final model: age, residence, body mass index, on‐treatment heart rate and BP, prior myocardial infarction, heart failure, stroke/transient ischemic attack, smoking, diabetes, peripheral arterial disease, and chronic kidney disease. The primary outcome occurred in 2.9% of the low‐risk group, 6.5% of the intermediate‐risk group, and 18.0% of the high‐risk group (
P
for trend <0.0001). The model was good at discriminating those who had an event versus those who did not (C‐statistic=0.75). The model performed well in a validation cohort (C‐statistic=0.77).
Conclusion
Readily available clinical variables can rapidly stratify patients with hypertension and chronic stable
CAD
into useful risk categories.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献